GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » ROCE %

Cilo Cybin Holdings (JSE:CCC) ROCE % : 0.00% (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cilo Cybin Holdings's annualized ROCE % for the quarter that ended in Mar. 2023 was 0.00%.


Cilo Cybin Holdings ROCE % Historical Data

The historical data trend for Cilo Cybin Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings ROCE % Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23
ROCE %
- -

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23
ROCE % - -

Cilo Cybin Holdings ROCE % Calculation

Cilo Cybin Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=-0.54/( ( (0.01 - 0) + (0.077 - 0.619) )/ 2 )
=-0.54/( (0.01+-0.542)/ 2 )
=-0.54/-0.266
=203.01 %

Cilo Cybin Holdings's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2023 )  (Q: Mar. 2022 )(Q: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2023 )  (Q: Mar. 2022 )(Q: Mar. 2023 )
=-0.54/( ( (0.01 - 0) + (0.077 - 0.619) )/ 2 )
=-0.54/( ( 0.01 + -0.542 )/ 2 )
=-0.54/-0.266
=0 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cilo Cybin Holdings  (JSE:CCC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Cilo Cybin Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cilo Cybin Holdings Business Description

Traded in Other Exchanges
N/A
Address
7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines